FONAR (FONR) Competitors $12.37 +0.07 (+0.57%) As of 05/2/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FONR vs. SMLR, NNOX, STIM, SMTI, ZIMV, RCEL, SNWV, NVRO, NYXH, and ELMDShould you be buying FONAR stock or one of its competitors? The main competitors of FONAR include Semler Scientific (SMLR), Nano-X Imaging (NNOX), Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), SANUWAVE Health (SNWV), Nevro (NVRO), Nyxoah (NYXH), and Electromed (ELMD). These companies are all part of the "medical equipment" industry. FONAR vs. Semler Scientific Nano-X Imaging Neuronetics Sanara MedTech ZimVie AVITA Medical SANUWAVE Health Nevro Nyxoah Electromed Semler Scientific (NASDAQ:SMLR) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, community ranking, profitability, earnings, institutional ownership and risk. Do analysts rate SMLR or FONR? Semler Scientific currently has a consensus target price of $71.00, indicating a potential upside of 96.35%. Given Semler Scientific's stronger consensus rating and higher probable upside, research analysts plainly believe Semler Scientific is more favorable than FONAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00FONAR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders & institutionals believe in SMLR or FONR? 49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 30.2% of Semler Scientific shares are held by insiders. Comparatively, 1.6% of FONAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has preferable valuation & earnings, SMLR or FONR? Semler Scientific has higher earnings, but lower revenue than FONAR. Semler Scientific is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemler Scientific$56.29M6.16$20.58M$4.917.36FONAR$101.57M0.75$10.57M$1.1510.70 Which has more risk and volatility, SMLR or FONR? Semler Scientific has a beta of 1.29, suggesting that its stock price is 29% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Does the media prefer SMLR or FONR? In the previous week, Semler Scientific had 4 more articles in the media than FONAR. MarketBeat recorded 5 mentions for Semler Scientific and 1 mentions for FONAR. FONAR's average media sentiment score of 1.44 beat Semler Scientific's score of 0.65 indicating that FONAR is being referred to more favorably in the news media. Company Overall Sentiment Semler Scientific Positive FONAR Positive Does the MarketBeat Community prefer SMLR or FONR? FONAR received 178 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 74.69% of users gave FONAR an outperform vote while only 66.67% of users gave Semler Scientific an outperform vote. CompanyUnderperformOutperformSemler ScientificOutperform Votes266.67% Underperform Votes133.33% FONAROutperform Votes18074.69% Underperform Votes6125.31% Is SMLR or FONR more profitable? Semler Scientific has a net margin of 72.65% compared to FONAR's net margin of 7.68%. Semler Scientific's return on equity of 50.77% beat FONAR's return on equity.Company Net Margins Return on Equity Return on Assets Semler Scientific72.65% 50.77% 47.04% FONAR 7.68%4.94%3.70% SummarySemler Scientific beats FONAR on 12 of the 18 factors compared between the two stocks. Get FONAR News Delivered to You Automatically Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FONR vs. The Competition Export to ExcelMetricFONARElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$76.46M$3.23B$5.55B$8.04BDividend YieldN/A1.80%5.09%4.22%P/E Ratio10.7015.5822.6818.83Price / Sales0.7558.98404.28106.72Price / Cash4.7844.0938.1834.62Price / Book0.483.616.794.33Net Income$10.57M$94.03M$3.22B$247.97M7 Day Performance2.41%2.78%2.44%2.71%1 Month Performance-9.08%6.32%3.78%3.37%1 Year Performance-24.29%-16.75%17.05%5.80% FONAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FONRFONAR2.3189 of 5 stars$12.31+0.1%N/A-24.3%$76.46M$101.57M10.70480Short Interest ↓Positive NewsSMLRSemler Scientific3.1526 of 5 stars$29.83-8.2%$71.00+138.0%+36.3%$286.28M$56.29M6.08120Upcoming EarningsGap UpNNOXNano-X Imaging2.6071 of 5 stars$4.75-8.7%$12.00+152.6%-44.3%$274.45M$11.28M-5.59190Positive NewsSTIMNeuronetics1.182 of 5 stars$3.88+3.2%$5.50+41.8%+30.9%$255.36M$74.89M-3.15180Upcoming EarningsNews CoverageSMTISanara MedTech2.0588 of 5 stars$28.66-2.6%$48.50+69.2%+6.1%$255.13M$86.67M-28.9560News CoveragePositive NewsZIMVZimVie2.6252 of 5 stars$8.92-5.0%$19.50+118.6%-40.9%$248.40M$449.75M-0.682,700Positive NewsRCELAVITA Medical1.5689 of 5 stars$9.10-1.2%$17.25+89.6%+6.0%$240.56M$64.25M-3.81130News CoverageGap DownSNWVSANUWAVE HealthN/A$28.00-6.6%N/AN/A$239.37M$32.63M-7.1840Positive NewsNVRONevroN/A$5.85+0.1%$5.36-8.3%-47.6%$224.32M$408.52M-3.091,090Upcoming EarningsAnalyst ForecastNYXHNyxoah2.1694 of 5 stars$5.94-1.5%$14.50+144.1%-37.9%$202.32M$4.52M-3.18110ELMDElectromed1.1117 of 5 stars$22.62-0.7%$38.00+68.0%+30.5%$193.56M$59.63M30.16160Analyst UpgradeNews CoveragePositive News Related Companies and Tools Related Companies Semler Scientific Competitors Nano-X Imaging Competitors Neuronetics Competitors Sanara MedTech Competitors ZimVie Competitors AVITA Medical Competitors SANUWAVE Health Competitors Nevro Competitors Nyxoah Competitors Electromed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FONR) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FONAR Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share FONAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.